Clinical Trial Update: Prediction of Everolimus-induced Interstitial Lung Disease

View source ↗

Summary

This document reports the completion of a clinical trial evaluating a predictive model for everolimus-induced interstitial lung disease in breast cancer patient…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Afinitor (everolimus)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Breast Neoplasms | Status: COMPLETED